Fig. 3From: EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancerCT scans of the thorax performed before (baseline) and after osimertinib treatment (PR or SD). CT, computed tomography; PR, partial response; SD, stable diseaseBack to article page